US2007249814A1PendingUtilityA1

Transcriptional regulatory factor

Assignee: CHUGAI PHARMACEUTICAL CO LTDPriority: Apr 30, 1998Filed: Mar 23, 2007Published: Oct 25, 2007
Est. expiryApr 30, 2018(expired)· nominal 20-yr term from priority
C07K 14/4702
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

BLAST search was done on the EST database by using various nucleotide sequences encoding known bromodomain motifs to discover several ESTs likely encoding bromodomain genes. Next, testicular cDNAs were PCR cloned by using primers designed based on the sequence of EST (W17142), which is one of the ESTs discovered above. By using the thus obtained PCR product as a probe, the testicular library was screened. The obtained cDNA clone was used as a probe to re-screen the testicular cDNA library, thereby successfully isolating a full-length cDNA corresponding to EST (W17142). The protein encoded by the thus isolated cDNA had, in addition to the bromodomain, several regions and domains conserved in transcription regulatory factors. Moreover, the protein interacted with proteins associated with the chromatin-mediated transcriptional regulatory mechanism and a transcription co-activator.

Claims

exact text as granted — not AI-modified
1 - 31 . (canceled)  
     
     
         32 . An isolated antibody that specifically binds to a polypeptide the sequence of which consists of SEQ ID NO: 1 or 10.  
     
     
         33 . The antibody of  claim 32 , wherein the antibody is polyclonal.  
     
     
         34 . The antibody of  claim 32 , wherein the antibody is monoclonal.  
     
     
         35 . The antibody of  claim 32 , wherein the antibody is a human antibody.  
     
     
         36 . The antibody of  claim 32 , wherein the antibody is a humanized antibody.  
     
     
         37 . The antibody of  claim 32 , wherein the antibody is an IgG.  
     
     
         38 . The antibody of  claim 32 , wherein the antibody is an IgM.  
     
     
         39 . An isolated antibody that specifically binds to a polypeptide the sequence of which consists of SEQ ID NO:1 or 10 with up to 50 conservative amino acid substitutions.  
     
     
         40 . The antibody of  claim 39 , wherein the number of conservative amino acid substitutions is up to 30.  
     
     
         41 . The antibody of  claim 39 , wherein the number of conservative amino acid substitutions is up to 10.  
     
     
         42 . The antibody of  claim 39 , wherein the number of conservative amino acid substitutions is up to 3.  
     
     
         43 . The antibody of  claim 39 , wherein the antibody is polyclonal.  
     
     
         44 . The antibody of  claim 39 , wherein the antibody is monoclonal.  
     
     
         45 . The antibody of  claim 39 , wherein the antibody is a human antibody.  
     
     
         46 . The antibody of  claim 39 , wherein the antibody is a humanized antibody.  
     
     
         47 . The antibody of  claim 39 , wherein the antibody is an IgG.  
     
     
         48 . The antibody of  claim 39 , wherein the antibody is an IgM.

Join the waitlist — get patent alerts

Track US2007249814A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.